Segulah Medical Acceleration
Overview
Segulah Medical Acceleration specializes in investing in and nurturing transformative businesses focused on medical technologies and associated value chain solutions . These companies leverage cutting-edge research to develop real-world applications in areas like medical devices, diagnostics, and life science tools . Segulah Medical Acceleration plays a pivotal role in bridging the gap between innovative concepts and commercial validation, facilitating the global market entry of advanced medical research solutions .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Quanta Dialysis Technologies | Jun 2021 | Series D | Co-investor |
| Navinci Diagnostics | Jun 2025 | Early Funding | Co-investor |
| Signifier Medical Technologies | Jun 2023 | Series E | Co-investor |
| Protembis GmbH | Mar 2024 | Series B | Lead |
| Collective Minds Radiology | Aug 2023 | Series B | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Segulah Medical Acceleration based?
Segulah Medical Acceleration is headquartered in Sweden.
When was Segulah Medical Acceleration founded?
Segulah Medical Acceleration was founded in 2021.
How many portfolio companies does Segulah Medical Acceleration have?
Segulah Medical Acceleration has 8 portfolio companies in Caplight's dataset.
What are some companies in Segulah Medical Acceleration's portfolio?
Portfolio companies visible on Caplight include Quanta Dialysis Technologies, Navinci Diagnostics, Signifier Medical Technologies, Protembis GmbH, Collective Minds Radiology.
What was Segulah Medical Acceleration's most recent investment shown here?
Segulah Medical Acceleration's most recent investment in this portfolio sample was in Navinci Diagnostics in 2025.
What sectors does Segulah Medical Acceleration focus on?
Segulah Medical Acceleration focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Frontier & Industrial Tech.
What company stages does Segulah Medical Acceleration focus on?
Segulah Medical Acceleration typically invests at the MultiStage stage.
What is Segulah Medical Acceleration's AUM?
Segulah Medical Acceleration's assets under management are estimated between $100.0M and $250.0M.